Igor Puzanov

Igor Puzanov

Roswell Park Comprehensive Cancer Center - Buffalo / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4607015
-
person_outline Igor Puzanov's MOST POPULAR ARTICLES
1-) Inhibition of mutated, activated BRAF in metastatic melanomaKT Flaherty, I Puzanov, KB Kim, A Ribas, GA McArthur, JA Sosman, ...New England Journal of Medicine 363 (9), 809-819, 201040182010
2-) Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice GuidelineJR Brahmer, C Lacchetti, BJ Schneider, MB Atkins, KJ Brassil, ...Journal of clinical oncology: official journal of the American Society of …, 201830442018
3-) Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutationsKT Flaherty, JR Infante, A Daud, R Gonzalez, RF Kefford, J Sosman, ...New England Journal of Medicine 367 (18), 1694-1703, 201229812012
4-) Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumabSL Topalian, M Sznol, DF McDermott, HM Kluger, RD Carvajal, ...Journal of clinical oncology 32 (10), 1020-1030, 201427332014
5-) Talimogene laherparepvec improves durable response rate in patients with advanced melanomaRHI Andtbacka, HL Kaufman, F Collichio, T Amatruda, N Senzer, ...Journal of clinical oncology 33 (25), 2780-2788, 201527262015